MAY 10, 2016 08:00 AM PDT

The art of war, unleashing the immune system to fight cancer

Speakers
  • Senior Principal Investigator and Director for Translational Immunology, Institute of Molecular and Cellular Biology (IMCB)
    Biography
      Dr. Connolly is a Senior Principal Investigator and Director for Translational Immunology at the Institute of Molecular and Cellular Biology (IMCB). Additionally, Dr. Connolly serves as Program Director for the A*Star Program in Translational Research in Infectious Disease, a multi-disciplinary center focused on vaccine development. As a human immunologist, his research focuses on immunotherapy for cancer and target discovery for immune modulation. In 2010 Dr. Connolly moved to Singapore to establish the Program in Translational Immunology at A*Star (Agency for Science, Technology and Research) a national training and infrastructure program linking all of the hospitals in Singapore and dedicated to the analysis of human disease in this uniquely diverse population. Dr. Connolly is Adjunct Associate Professor of Immunology at Baylor University.

      Dr. Connolly received his Ph.D. in Immunology from Dartmouth Medical School and studied human dendritic cell biology under Dr. Michael Fanger. During this time he was involved in the development of immunotherapeutic preclinical models and clinical trials for Glioblastoma multiforme (GBM). He moved to the Baylor Institute for Immunology Research, a fully translational research institute dedicated to rationally designed biologics, vaccines and cell therapy for cancer. Dr. Connolly served as the Director of Research Initiatives for the Baylor Research Institute, a large integrated translational research resource and multi-institutional programs that involved a number of international sites. During his tenure at Baylor, Dr. Connolly was the central core facility director of the NIAID Centers for Translational Research on Human Immunology and Biodefense, an NIH funded consortium of basic, translational research and clinical trials focused on vaccine design. Dr. Connolly is the past President of the Board of Directors of The American Cancer Society in N. Texas and founding Director of the Singapore Immunology Network's Immunomonitoring Platform.

    Abstract:
    DATE: May 10th, 2016
    TIME:  8:00am Pacific time, 11:00am Eastern time


    Cancer is a complex, multifactorial disease that not only is a cause of major human suffering throughout history, but continues to represent an enormous burden to society. In most cases long term treatment remains elusive primarily because the underlying cause does not often lie in a single defect but rather large number of small effects arising from lifestyle, environment and underlying genetic predispositions. Recent advances in our understanding of the human immune system and cancer immune evasion have led to nothing less than a revolution in cancer treatment. The development of effective immune checkpoint inhibitors, and novel cell therapy strategies have resulted unprecedented responses across a number indications with dramatic increases in durable disease control and long term survival. We will discuss the evolution of our view of the immune system and highlight the breakthroughs which provide a framework to develop the next generation of cancer therapeutics

    Show Resources
    You May Also Like
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 29, 2018 09:00 AM PDT
    C.E. CREDITS
    MAY 29, 2018 09:00 AM PDT
    Recent advances in immuno-oncology research has proven the critical role of immune cells in cancer therapy. Deep understanding of the interaction and phenotype of immune and tumor cells withi...
    Loading Comments...